Private Advisor Group, LLC Exelixis, Inc. Transaction History

Private Advisor Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$20.67 - $26.94 $24,369 - $31,762	-1,179 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$16.46 - $27.42 $19,406 - $32,328	1,179 New	1,179 $28,000
Q3 2019 Nov 13, 2019	SELL	$17.68 - $22.65 $238,503 - $305,548	-13,490 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.93 - $24.75 $255,365 - $333,877	13,490 New	13,490 $288,000
Q1 2018 May 09, 2018	SELL	$22.15 - $31.89 $201,166 - $289,624	-9,082 Closed	0 $0
Q4 2017 Feb 07, 2018	SELL	$24.23 - $30.93 $34,140 - $43,580	-1,409 Reduced 13.43%	9,082 $266,000
Q3 2017 Nov 13, 2017	BUY	$23.35 - $29.24 $19,147 - $23,976	820 Added 8.48%	10,491 $269,000
Q2 2017 Aug 10, 2017	BUY	N/A	9,671	9,671 $247,000

613

257M

1.57M

730K

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $13.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.